Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa

Taylor, R F; Hodson, M E; Pitt, T L
October 1993
Thorax;Oct1993, Vol. 48 Issue 10, p1002
Academic Journal
No abstract available.


Related Articles

  • Inhaled tobramycin improves lung function and bacterial density associated with Pseudomonas aeruginosa infections in patients with cystic fibrosis. Adis International Limited // Drugs & Therapy Perspectives;Sep2004, Vol. 20 Issue 9, p1 

    Focuses on the effects of inhaled tobramycin on lung function and bacterial density associated with Pseudomonas aeruginosa infections in cystic fibrosis patients. Clinical benefits and potential limitations of tobramycin solution for inhalation (TSI) in the management of Pseudomonas aeruginosa...

  • The spectrum of cystic fibrosis exacerbations.  // Thorax;Dec2006 Supplement 2, Vol. 61, pii33 

    The article presents abstracts of medical research related to the spectrum of cystic fibrosis exacerbations. They include "Characterization of Bacterial Diversity in Cystic Fibrosis Sputum," "Outcome of Burkholderia Cepacia Complex Pulmonary Infection in Patients with Cystic Fibrosis from...

  • Chronic Pseudomonas aeruginosa Infection in Chronic Obstructive Pulmonary Disease. Martínez-Solano, Laura; Macia, María D.; Fajardo, Alicia; Oliver, Antonio; Martinez, Jose L. // Clinical Infectious Diseases;12/15/2008, Vol. 47 Issue 12, p1526 

    Background. Pseudomonas aeruginosa infections are increasingly associated with acute exacerbations in chronic obstructive pulmonary disease (COPD). We aimed to determine whether an underlying chronic infection might be behind this process and to determine the epidemiological characteristics of...

  • Kistik fibrozisli çocukta düzelmeyen öksürük nedeni olarak Pseudomonas aeruginosa pnömonisi: Olgu sunumu. Kutlu, Ruhuşen; Pekcan, Sevgi; Işıklar Özberk, Derya // Turkish Journal of Family Practice / Türkiye Aile Hekimligi Der;2013, Vol. 17 Issue 4, p157 

    Cystic fibrosis (CF) is a disease which is caused by a mutation in the transmembrane conductance regulator gene, and displays autosomal recessive heredity. Cystic fibrosis trans-membrane regulator protein (CFTR) is required to regulate the components of sweat, digestive fluids, and mucus. The...

  • Case Fourteen: Full of Slime. Muldoon, Jean F.; Mortensen, Joel E. // Journal of Continuing Education Topics & Issues;Jan2007, Vol. 9 Issue 1, p26 

    The article discusses a clinical microbiology case involving a 14-year-old female patient with cystic fibrosis (CF). The disease is characterized by chronic obstructive pulmonary disease, exocrine pancreatic insufficiency and abnormally high sweat electrolytes. Several infectious agents are...

  • Allergic Bronchopulmonary Aspergillosis in Patient with Cystic Fibrosis - a Case Report. IONESCU, Marcela Daniela; BALGRADEAN, Mihaela; MARCU, Veronica // Maedica - a Journal of Clinical Medicine;2014, Vol. 9 Issue 4, p387 

    Asthma with allergic bronchopulmonary aspergillosis (ABPA), a hypersensitivity disease of the lungs due to an immune response to Aspergillus fumigattus (Af) antigens, is rarely seen in children, other than complicating cystic fibrosis. We present the case of a 14 - year- old female teenager with...

  • Effect of Estrogen on Pseudomonas Mucoidy and Exacerbations in Cystic Fibrosis. Chotirmall, Sanjay H.; Smith, Stephen G.; Gunaratnam, Cedric; Cosgrove, Sonya; Dimitrov, Borislav D.; O'Neill, Shane J.; Harvey, Brian J.; Greene, Catherine M.; McElvaney, Noel G. // New England Journal of Medicine;5/24/2012, Vol. 366 Issue 21, p1978 

    Background: Women with cystic fibrosis are at increased risk for mucoid conversion of Pseudomonas aeruginosa, which contributes to a sexual dichotomy in disease severity. Methods: We evaluated the effects of estradiol and its metabolite estriol on P. aeruginosa in vitro and in vivo and...

  • Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis. Girón-Moreno, Rosa Maria; Justicia, José L.; Yamamoto, Sara; Valenzuela, Claudia; Cisneros, Carolina; Gómez-Punter, Rosa Mar; Fernandes-Vasconcelos, Gilda; Ancochea, Julio // BMC Pulmonary Medicine;2014, Vol. 14 Issue 1, p150 

    Background: Pulmonary exacerbation is one of the main risk factors for death in patients with cystic fibrosis. Several biomarkers have proven useful in the diagnosis and treatment of pulmonary exacerbations, although none has been associated with severity. The objective of the present study was...

  • Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice. Legssyer, Rachida; Huaux, François; Lebacq, Jean; Delos, Monique; Marbaix, Etienne; Lebecque, Patrick; Lison, Dominique; Scholte, Bob J.; Wallemacq, Pierre; Leal, Teresinha // Respiratory Research;2006, Vol. 7, p134 

    Background: Inflammation plays a critical role in lung disease development and progression in cystic fibrosis. Azithromycin is used for the treatment of cystic fibrosis lung disease, although its mechanisms of action are poorly understood. We tested the hypothesis that azithromycin modulates...

  • The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations. Fodor, Anthony A.; Klem, Erich R.; Gilpin, Deirdre F.; Elborn, J. Stuart; Boucher, Richard C.; Tunney, Michael M.; Wolfgang, Matthew C.; Fleiszig, Suzanne // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Cystic fibrosis (CF) is characterized by defective mucociliary clearance and chronic airway infection by a complex microbiota. Infection, persistent inflammation and periodic episodes of acute pulmonary exacerbation contribute to an irreversible decline in CF lung function. While the factors...


Read the Article


Sign out of this library

Other Topics